Quickstart Highlights CagriSema is an investigational once-weekly, fixed-dose combination of two metabolic peptides in a single subcutaneous injection cagrilintide , a long-acting analog of the pancreatic hormone amylin, and semaglutide , a GLP-1 receptor agonist
It is prescribed as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) that is considered outside a healthy range
The ingredients they use either havent been studied well or only show very small effects even when taken by mouth
Once inside the cell, the acetyl group is removed, releasing active glutathione where its needed most
The report has been named Editor's Pick of the Month for September 2013 by the Journal's Editor-in-Chief Bryon Adinoff, M.D., Distinguished Professor in Drug and Alcohol Abuse Research at the University of Texas Southwestern Medical Center